Cetera Investment Advisers - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cetera Investment Advisers ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$201,943
-56.0%
1,270
-53.1%
0.00%
-50.0%
Q4 2022$458,491
+23.3%
2,708
+36.2%
0.00%
-42.9%
Q3 2022$372,000
+18.8%
1,988
+3.1%
0.01%
+40.0%
Q2 2022$313,000
-21.0%
1,929
-8.5%
0.01%
-16.7%
Q1 2022$396,000
-12.6%
2,108
+23.3%
0.01%0.0%
Q4 2021$453,000
-11.4%
1,709
-3.3%
0.01%
-25.0%
Q3 2021$511,0001,7670.01%
Other shareholders
REPLIGEN CORP shareholders Q3 2023
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders